Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations Between Opioid Timing and Postoperative Desaturation Burden Following Metabolic Bariatric Surgery.

Obesity surgery·2026
Same author

Lessons from biotech's unscientific evolution.

Nature biotechnology·2026
Same author

Investigating the correlation between force output, strains, and pressure for active skeletal muscle contractions.

Journal of the mechanical behavior of biomedical materials·2026
Same author

Few-Shot Transfer Learning for Diabetes Risk Prediction Across Global Populations.

Medicina (Kaunas, Lithuania)·2026
Same author

Point-of-Care Tongue Ultrasound for Perioperative Risk Stratification in Metabolic Bariatric Surgery.

Obesity surgery·2025
Same author

Worsening versus advanced heart failure: Management and challenges.

ESC heart failure·2025

Related Experiment Video

Updated: Jun 28, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
08:11

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

Published on: November 11, 2022

Digoxin: current use and approach to toxicity.

Rey P Vivo1, Selim R Krim, Joanne Perez

  • 1Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas 79430-9410, USA. rey.vivo@ttuhsc.edu

The American Journal of the Medical Sciences
|November 18, 2008
PubMed
Summary

Digoxin is an old but effective heart medication for heart failure and atrial fibrillation. Early recognition of its toxicity is crucial due to nonspecific symptoms and patient vulnerability.

Related Experiment Videos

Last Updated: Jun 28, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
08:11

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

Published on: November 11, 2022

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Digoxin, the oldest cardiovascular drug, is still vital for treating heart failure and atrial fibrillation.
  • Its use persists despite newer drug options due to its proven efficacy.

Purpose of the Study:

  • To highlight digoxin's continued relevance in cardiovascular therapy.
  • To emphasize the importance of recognizing and managing digoxin toxicity.

Main Methods:

  • Review of digoxin's hemodynamic, neurohormonal, and electrophysiologic actions.
  • Analysis of factors increasing patient vulnerability to digoxin toxicity.

Main Results:

  • Digoxin offers evidence-based adjunctive therapy for heart failure and atrial fibrillation.
  • Aging, comorbidities, and polypharmacy increase patient risk for digoxin toxicity.

Conclusions:

  • Digoxin remains a valuable therapeutic option.
  • A high index of suspicion is essential for early diagnosis and management of digoxin toxicity due to nonspecific signs and symptoms.